Trial Profile
The Post-Marketing Safety and Effectiveness of Peramivir in Korean Adults with Seasonal Influenza
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Aug 2018
Price :
$35
*
At a glance
- Drugs Peramivir (Primary)
- Indications Influenza virus infections
- Focus Therapeutic Use
- 17 Aug 2018 New trial record
- 06 Aug 2018 Results published in the Journal of Korean Medical Science.
- 06 Aug 2018 Results published in the Journal of Korean Medical Science